ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,083Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 434

$746K Total Retail Price of All Prescriptions

Rank: 14 out of 434

1,162 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 1,162 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 1,162 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 17,448 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 1,418 1,210 1 1
SIMVASTATIN 1,048 938 2 2
LEVOTHYROXINE SODIUM 892 799 3 3
OMEPRAZOLE 826 674 4 5
HYDROCODONE-ACETAMINOPHEN 824 568 S3 5 4
METOPROLOL SUCCINATE 683 575 6 22
AMLODIPINE BESYLATE 572 485 7 6
ALENDRONATE SODIUM 470 455 8 15
GABAPENTIN 466 348 9 14
PRAVASTATIN SODIUM 409 323 10 17
HYDROCHLOROTHIAZIDE 377 326 11 8
METFORMIN HCL 360 319 12 7
MORPHINE SULFATE ER 337 159 S2 13 50
LOVASTATIN 329 325 14 10
TERAZOSIN HCL 308 278 15 40
LOSARTAN POTASSIUM 294 263 16 13
ATENOLOL 292 249 17 16
FUROSEMIDE 285 242 18 9
METOPROLOL TARTRATE 281 256 19 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 280 252 20 21
SPIRIVA 261 237 21 36
CITALOPRAM HBR 259 193 22 23
METFORMIN HCL ER 233 221 23 48
VENTOLIN HFA 213 189 24 30
CARVEDILOL 209 193 25 24
SERTRALINE HCL 194 145 26 27
WARFARIN SODIUM 184 162 27 18
ALLOPURINOL 176 160 28 25
FENOFIBRATE 172 150 29 43
TRAZODONE HCL 168 104 30 33
ROPINIROLE HCL 165 125 31 104
FLUTICASONE PROPIONATE 163 123 32 26
ZOLPIDEM TARTRATE 158 131 33 11
DONEPEZIL HCL 153 153 34 35
CLONIDINE HCL 152 129 35 63
ISOSORBIDE MONONITRATE ER 152 142 35 68
GEMFIBROZIL 148 134 37 62
ATORVASTATIN CALCIUM 140 113 38 19
GLIPIZIDE 140 125 38 37
POLYETHYLENE GLYCOL 3350 139 122 40 81
MELOXICAM 134 96 41 46
POTASSIUM CHLORIDE 134 94 41 20
GLYBURIDE 122 116 R 43 51
TAMSULOSIN HCL 116 99 44 29
PREDNISONE 116 85 44 42
TRAMADOL HCL 114 89 46 28
CARISOPRODOL 114 36 R 46 44
BENAZEPRIL HCL 109 108 48 49
LANTUS SOLOSTAR 109 97 48 71
GLIPIZIDE ER 107 99 50 65
OXYBUTYNIN CHLORIDE ER 105 97 51 91
RANITIDINE HCL 105 75 51 31
OXYCODONE HCL-ACETAMINOPHEN 103 50 S2 53 53
CLOPIDOGREL 101 89 54 41
IBUPROFEN 99 79 55 56
HYDRALAZINE HCL 91 84 56 79
DIGOXIN 89 85 57 69
PANTOPRAZOLE SODIUM 88 81 58 66
NIFEDIPINE ER 84 78 59 86
FINASTERIDE 80 68 60 54
FLUOXETINE HCL 79 59 61 32
NAMENDA 77 77 62 72
CELEBREX 77 75 62 144
TRIAMCINOLONE ACETONIDE 73 57 64 94
SYMBICORT 71 56 65 93
AMITRIPTYLINE HCL 69 38 R 66 57
DICLOFENAC SODIUM 68 54 67 92
PEN NEEDLE 68 57 67 83
BENICAR 63 54 69 121
VESICARE 59 58 70 264
GLYBURIDE-METFORMIN HCL 59 59 R 70 118
PLAVIX 58 56 72 64
GLIMEPIRIDE 58 56 72 58
OXYCODONE HCL 58 35 S2 72 34
PAROXETINE HCL 56 35 75 61
LOSARTAN-HYDROCHLOROTHIAZIDE 54 50 76 39
RISPERIDONE 50 23 77 87
CIPROFLOXACIN HCL 50 45 77 55
TRIAMTERENE-HCTZ 50 43 77 47
INSULIN SYRINGE 50 26 77 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.